LABORATORY RESEARCH Identification of Multipotent Mammary Stem Cells by Protein C Receptor Expression Researchers demonstrate that protein C receptor (Procr), a novel Wnt target in the mammary gland, marks a unique population of multipotent mouse mammary stem cells . Procr-positive cells localize to the basal layer, exhibit epithelial-to-mesenchymal transition characteristics, and express low levels of basal keratins. [Nature] Abstract Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis Investigators report that breast cancer associated exosomes contain microRNAs (miRNAs) associated with the RISC-Loading Complex and display cell-independent capacity to process precursor miRNAs into mature miRNAs. Exosomes derived from cells and sera of patients with breast cancer instigate nontumorigenic epithelial cells to form tumors in a Dicer-dependent manner. [Cancer Cell] Abstract | Editorial | Press Release MSC-Regulated MicroRNAs Converge on the Transcription Factor FOXP2 and Promote Breast Cancer Metastasis Researchers show that mesenchymal stem/stromal cells (MSCs) cause aberrant expression of microRNAs, which, led by microRNA-199a, provide breast cancer cells with enhanced cancer stem cell properties. They demonstrate that such MSC-deregulated microRNAs constitute a network that converges on and represses the expression of FOXP2, a forkhead transcription factor tightly associated with speech and language development. [Cell Stem Cell] Abstract | Graphical Abstract | Press Release Pluripotent Stem Cell miRNAs and Metastasis in Invasive Breast Cancer Researchers determined whether microRNA (miRNA) for pluripotent stem cells are also expressed in breast cancer and are associated with metastasis and outcome. [J Natl Cancer Inst] Abstract TOPK Inhibitor Induces Complete Tumor Regression in Xenograft Models of Human Cancer through Inhibition of Cytokinesis TOPK (T-lymphokine-activated killer cell-originated protein kinase) is highly and frequently transactivated in various cancer tissues, including lung and triple-negative breast cancers, and plays an indispensable role in the mitosis of cancer cells. The authors report the development of a potent TOPK inhibitor, OTS964, which inhibits TOPK kinase activity with high affinity and selectivity. [Sci Transl Med] Abstract | Press Release Single-Cell Analyses of Transcriptional Heterogeneity during Drug Tolerance Transition in Cancer Cells by RNA Sequencing Scientists performed whole transcriptome sequencing analyses of metastatic human breast cancer cells subjected to the chemotherapeutic agent paclitaxel at the single-cell and population levels. They show that specific transcriptional programs are enacted within untreated, stressed, and drug-tolerant cell groups while generating high heterogeneity between single cells within and between groups. [Proc Natl Acad Sci USA] Abstract | Press Release | Video Combined Deletion of Pten and p53 in Mammary Epithelium Accelerates Triple-Negative Breast Cancer with Dependency on eEF2K Investigators show that mammary-specific deletion of Pten via WAP-Cre, which targets alveolar progenitors, induced tumors with shortened latency compared to those induced by MMTV-Cre, which targets basal/luminal progenitors. Combined Pten-p53 mutations accelerated formation of claudin-low, triple-negative-like breast cancer that exhibited hyper-activated AKT signaling and more mesenchymal features relative to Pten or p53 single-mutant tumors. [EMBO Mol Med] Full Article Anatomical Localization of Progenitor Cells in Human Breast Tissue Reveals Enrichment of Uncommitted Cells within Immature Lobules Scientists characterized the mammary progenitor cell hierarchy and identified the anatomic location of progenitor cells within human breast tissues. [Breast Cancer Res] Abstract | Full Article Integrative Investigation on Breast Cancer in ER, PR and HER2-Defined Subgroups Using mRNA and miRNA Expression Profiling Investigators explored the intrinsic differences among breast cancer subgroups defined by immunohistochemical expression of hormone receptors ER and PR as well as human epidermal growth factor receptor 2 (HER2) using the mRNA and miRNA expression profiles of 115 tumors. [Sci Rep] Full Article Inhibition of Triple-Negative and Herceptin-Resistant Breast Cancer Cell Proliferation and Migration by Annexin A2 Antibodies Researchers demonstrate that annexin A2 interacts with epidermal growth factor receptor (EGFR) at the cell surface and has an important role in cancer cell proliferation and migration by modulating EGFR functions. [Br J Cancer] Abstract CLINICAL RESEARCH Trastuzumab Plus Adjuvant Chemotherapy for Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: Planned Joint Analysis of Overall Survival From NSABP B-31 and NCCTG N9831 Positive interim analysis findings from four large adjuvant trials evaluating trastuzumab in patients with early-stage human epidermal growth factor receptor 2 (HER2)-positive breast cancer were previously reported. Investigators now report the planned definitive overall survival results from this joint analysis along with updates on the disease-free survival end point. [J Clin Oncol] Abstract | Full Article | Press Release Anastrozole versus Tamoxifen as Adjuvant Therapy for Japanese Postmenopausal Patients with Hormone-Responsive Breast Cancer: Efficacy Results of Long-Term Follow-Up Data from the N-SAS BC 03 Trial Investigators report the follow-up efficacy results from the N-SAS BC 03 trial where anastrozole was compared with tamoxifen as adjuvant therapy in postmenopausal Japanese patients with hormone-responsive early breast cancer. [Breast Cancer Res Treat] Abstract |